Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial

por Cohn, Allen Lee, Yoshino, Takayuki, Heinemann, Volker, Obermannova, Radka, Bodoky, György, Prausová, Jana, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Garcia-Alfonso, Pilar, Portnoy, David C., Van Cutsem, Eric, Yamazaki, Kentaro, Clingan, Philip R., Polikoff, Jonathon, Lonardi, Sara, O’Brien, Lisa M., Gao, Ling, Yang, Ling, Ferry, David, Nasroulah, Federico, Tabernero, Josep
Publicado 2017

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

por Tap, William D., Singh, Arun S., Anthony, Stephen Patrick, Sterba, Mike, Zhang, Chao, Healey, John H., Chmielowski, Bartosz, Cohn, Allen Lee, Shapiro, Geoffrey I., Keedy, Vicki L., Wainberg, Zev A., Puzanov, Igor, Cote, Gregory M., Wagner, Andrew J., Braiteh, Fadi, Sherman, Eric, Hsu, Henry H., Peterfy, Charles, Gelhorn, Heather L., Ye, Xin, Severson, Paul, West, Brian L., Lin, Paul S., Tong-Starksen, Sandra
Publicado 2022